CELL AND GENE THERAPY INSIGHTS

Can AAV continue to deliver the promise of gene therapy?

Can AAV continue to deliver the promise of gene therapy?

Ratish Krishnan, Elie Hanania
14 September 2023
Podcast
Happy medium: considerations in scaling cell culture media strategies

Happy medium: considerations in scaling cell culture media strategies

Dalip Sethi
17 August 2023
Podcast
Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?

Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?

Valeria Annibaldi, Andrea Toell
01 August 2023
Podcast
Modernizing cell therapy manufacturing to reduce vein-to-vein times

Modernizing cell therapy manufacturing to reduce vein-to-vein times

David Backer, Tony Ward
27 July 2023
Podcast
Interview: Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development

Interview: Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development

Paul Byrne
10 June 2023
Podcast
Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics

Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics

Jai Balkissoon, Vito Romita
06 April 2023
Podcast
Investing long-term in the cell & gene therapies of the future

Investing long-term in the cell & gene therapies of the future

Geeta Vemuri
29 March 2023
Podcast
Challenges in cryogenic storage containers for cell & gene therapy

Challenges in cryogenic storage containers for cell & gene therapy

Alex Sargent, Sean Werner
26 March 2023
Podcast
Maximizing efficiency & flexibility in viral vector manufacturing scale-up

Maximizing efficiency & flexibility in viral vector manufacturing scale-up

D Kole, J Petrone, M Bisschops et al
07 March 2023
Podcast
Improvement of viral vector purification using Mustang®️ Q membrane chromatography

Improvement of viral vector purification using Mustang®️ Q membrane chromatography

09 January 2023
Podcast
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing

Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing

Ratish Krishnan, Akshat Gupta
10 November 2022
Podcast
CAR-T cells: from cancer to autoimmunity

CAR-T cells: from cancer to autoimmunity

Dimitrios Mougiakakos
11 October 2022
Podcast
Tales, tips & teachable moments from applications support veterans

Tales, tips & teachable moments from applications support veterans

Chris Suarez, Catherine Siler, Austin Mogen
09 October 2022
Podcast
Learning from pediatric CAR-T development: insights from manufacturing unique patient doses

Learning from pediatric CAR-T development: insights from manufacturing unique patient doses

Chris Brown
22 September 2022
Podcast
Working together to safely advance cell & gene therapies

Working together to safely advance cell & gene therapies

J Maher, A J King, F Neethling et al
12 September 2022
Podcast
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us

Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us

Tom Foti, Kris Saha
30 August 2022
Podcast
Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy space

Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy space

Amritha Jaishankar
28 August 2022
Podcast
Achieving better AAV vector productivity and product quality

Achieving better AAV vector productivity and product quality

Diane Golebiowski, Marissa Stanvick
22 July 2022
Podcast
Partnering in life sciences: What is the secret sauce for success? PART 1: The Big Pharma perspective

Partnering in life sciences: What is the secret sauce for success? PART 1: The Big Pharma perspective

Marianne De Backer
15 July 2022
Podcast
Where will tomorrow’s workforce come from? PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t?

Where will tomorrow’s workforce come from? PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t?

S Kili, M Lehmicke, Q Rafiq et al
14 June 2022
Podcast
Where will tomorrow’s workforce come from? Part 2: How is the educational system responding, and how can the cell and gene therapy community at large help?

Where will tomorrow’s workforce come from? Part 2: How is the educational system responding, and how can the cell and gene therapy community at large help?

S Kili, M Lehmicke, Q Rafiq et al
02 June 2022
Podcast